Antineoplastic Resistance

Antineoplastic resistance, often used interchangeably with chemotherapy resistance, is the multiple drug resistance of neoplastic (cancerous) cells, or the ability of cancer cells to survive and grow despite anti-cancer therapies.

  • Tumor heterogeneity
  • Mechanisms of acquired antineoplastic resistance
  • Genetic markers for drug sensitivity and resistance
  • Genetic approaches to overcome drug resistance

Related Conference of Antineoplastic Resistance

February 05-06, 2026

11th World Conference on Breast and Cervical Cancer

Paris, France
February 19-20, 2026

7th Cancer Diagnostics & Treatment Conference

Miami, USA
February 19-20, 2026

8th International Conference on Women Oncology

Miami, USA
March 09-10, 2026

4th World Congress on Oral Cancer

Singapore City, Singapore
March 30-31, 2026

26th World Congress on Cancer and Diagnostics

London, UK
June 15-16, 2026

10th Global Meeting on Oncology and Radiology

Paris, France
June 22-23, 2026

16th World Congress on Breast Cancer

Dubai, UAE
June 23-24, 2026

27th World Congress on Cancer Summit

Paris, France
July 27-28, 2026

6th World Congress on Breast Cancer

Rome, Italy
September 28-29, 2026

36th Experts Meet On Cancer Research & Therapy

Aix-en-Provence, France
September 29-30, 2026

5th Experts Meeting on Cancer Medicine, Radiology & Treatment

Aix-en-Provence, France
February 24 - 25

Cancer Center Business Summit

Phoenix USA
July 14-15 2016

International Conference on Nuclear Medicine Radiation Therapy

Cologne Germany
May 4-6 2016

Accelerating Anticancer Agent Development and Validation Workshop

Bethesda USA
June 23 - 25 2016

The MASCC ISOO Annual Meeting on Supportive Care in Cancer

Adelaide Australia
November 29 - December 2

EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium

Munich Germany
May 23 - 24 2016

18th International Conference on Medical Microbiology Antimicrobial Agents and Chemotherapy

London United Kingdom
Jan 15-16 2016

Cancer Survivorship Symposium Advancing Care and Research A Primary Care and Oncology Symposium

San Francisco USA
May 4-6 2016

Accelerating Anticancer Agent Development and Validation Workshop

Bethesda USA

Antineoplastic Resistance Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in